SLT-Particles for Two-Step Targeting in Boron Neutron Capture Therapy
There are investigations proposing that liposomes, both stabilized and unstabilized, gather at sites of pathology, such as tumors, infections, and inflammations.1, 2, 3, 4 The site-specific uptake of liposomal substances ought to increase with a targeting agent on the liposome. One way to conduct the targeting is to use PEG (polyethylene glycol) as a spacer and conjugate the targeting agent to the terminus of the polymer.5 This conjugated liposome can be named a SLT-particle (stabilized liposome with targeting ligand).
KeywordsFormalin Toxicity Cage Bromide Boron
Unable to display preview. Download preview PDF.
- 4.M. Woodle. Sterically stabilized liposome therapeutics. Advanced Drug Delivery Reviews, 16:249–265.Google Scholar
- 7.H. Ghaneolhosseini. Boron Neutron Capture Therapy, Synthesis of Boronated Amines- and DNA Intercalating Agents for Potential Use in Cancer Therapy. Acta Universitatis Uppsaliensis, Comprehensive summaries of Uppsala Dissertations from the Faculty of Science and Technology, 356:62 pp. ISBN 91-554-4181-5, 1998.Google Scholar
- 8.L. Gedda. Boron Neutron Capture Therapy, Preclinical Studies of Compounds for Tumour Targeting. Acta Universitatis Uppsaliensis, Comprehensive Summaries of Dissertations from the Faculty of Medicine, 724:66 pp ISBN 91-554-4090-8. 1997.Google Scholar
- 9.P. Lindström, P. Olsson, J. Malmqvist, J. Pettersson, P. Lemmen, B. Werner, S. Sjöberg, Å. Olin, and J. Carlsson. New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells. Anti-Cancer Drugs. 5:43–52, 1994.PubMedCrossRefGoogle Scholar